Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-06-18

Protein S-Nitrosylation in Inflammation and Cancer

Objetivo

Chronic inflammation represents a major pathologic basis for many human cancers. Nitric oxide (NO) production is a hallmark of inflammation, and may play a significant role in inflammation-associated cancers. S-nitrosylation, the covalent attachment of an NO group to the thiol side chain of cysteine is a common mechanism for dynamic, post-translational regulation of most or all main classes of protein. Indeed, protein S-nitrosylation and denitrosylation have emerged as integral components of signal transduction pathways, and accumulating evidence suggests that deregulated S-nitrosylation contributes to a range of human pathologies. Yet, the involvement of protein S-nitrosylation/denitrosylation in inflammation-related cancer remains unclear. To elucidate the role of protein S-nitrosylation in inflammation-associated cancer we will employ models of lung cancer, where we will characterize the S-nitrosylated proteome, investigate denitrosylation mechanisms, and study the redox regulation of central mediators of inflammation. We focus on three areas of research: (1) advanced redox proteomics for the identification S-nitrosylated proteins in lung tumour cells and in lung macrophages; (2) characterization of the regulation by S-nitrosylation of key inflammatory mediators, particularly, the inflammasome; (3) investigation of mechanisms and consequences of protein denitrosylation in lung cancer cells.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Convocatoria de propuestas

FP7-PEOPLE-2009-RG
Consulte otros proyectos de esta convocatoria

Régimen de financiación

MC-IRG - International Re-integration Grants (IRG)

Coordinador

TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Aportación de la UE
€ 100 000,00
Coste total
Sin datos